Skip to main content
. 2007 Jan 29;104(6):1943–1946. doi: 10.1073/pnas.0610860104

Fig. 1.

Fig. 1.

Effect of treatment with GHRH antagonist JMR-132 given s.c. at a dose of 10 μg/day, docetaxel given i.p. at a dose of 20 milligrams per kilogram of body weight on days 1 and 5, or the combination of JMR-132 with docetaxel on the tumor volume of MX-1 human breast cancer xenografted s.c. into nude mice. Vertical bars indicate SE. *, P < 0.001 vs. control; **, P < 0.001 vs. control and the groups receiving single agents.